Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'pi3 kinase p110'

Search results for: 'pi3 kinase p110'

Items 641-650 of 674

Page
per page
  1. IRAK-1-4 Inhibitor I
    A3505 IRAK-1-4 Inhibitor I
     3 Citation
    Target: IRAK
    Summary: IRAK-1/4 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.75 mg/mL
  2. Y-27632
    B1293 Y-27632
     9 Citation
    Target: ROCK
    Summary: ROCK inhibitor,potent and selective
      ≥24.7 mg/mL
  3. Plumbagin
    A4456 Plumbagin
    Summary: Anticancer agent
  4. CAL-101 (Idelalisib, GS-1101)
    A3005 CAL-101 (Idelalisib, GS-1101)
     2 Citation
    Target: PI3K
    Summary: PI3K inhibitor
  5. Epidermal Growth Factor Receptor Peptide (985-996)
    A1021 Epidermal Growth Factor Receptor Peptide (985-996)
    Summary: EGFR Peptide (985-996)
      insoluble in EtOH; ≥10.12 mg/mL
  6. LRRK2-IN-1
    A3558 LRRK2-IN-1
     1 Citation
    Target: LRRK2|DCLK2
    Summary: LRRK2 inhibitor,cell-permeable and ATP competitive
      ≥28.55 mg/mL
  7. Dibutyryl-cAMP, sodium salt
    B9001 Dibutyryl-cAMP, sodium salt
    Summary: Cell-permeable cAMP analog that activates cAMP-dependent protein kinases
      ≥49.1 mg/mL
  8. Dasatinib Monohydrate
    B5954 Dasatinib Monohydrate
    Target: PDGFR|c-Kit|Bcr-Abl|Src
    Summary: Inhibitor of ABL, SRC, KIT, PDGFR, and other tyrosine kinases.
      ≥25.3 mg/mL
  9. RWJ 67657
    C5316 RWJ 67657
    Summary: orally active inhibitor of the MAP kinases p38α and p38β
      ≤10 mg/mL
  10. WP1130
    A8323 WP1130
     1 Citation
    Summary: Deubiquitinase (DUB) inhibitor, Cell permeable
      ≥38.4 mg/mL

Items 641-650 of 674

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways 634item
  2. Natural Products 5item
  3. Kits 5item
  4. Screening Library 12item
  5. Peptides 1 item
  6. Cell Biology 1 item
  7. Peptides & Proteins 7item
  8. Lab Reagents 1 item
Specificity
  1. Selective 239item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 24item
  2. Irreversible 8item
Target
  1. Cyclin-Dependent Kinases 27item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 4item
  4. PI3K 16item
  5. Raf 10item
  6. Aurora Kinases 21item
  7. CSF-1R 4item
  8. mTOR 8item
  9. FLT3 13item
  10. GSK-3 9item
  11. PLK 6item
  12. Chk 5item
  13. Eph Receptors 3item
  14. VEGFR 30item
  15. PDGFR 22item
  16. c-Kit 12item
  17. RET 4item
  18. IRAK 3item
  19. Bromodomain-containing proteins(BRDs) 1 item
  20. p38 6item
  21. PKB 1 item
  22. JNK 2item
  23. SGK 2item
  24. Bcr-Abl 13item
  25. MEK 4item
  26. FGFR 12item
  27. Pim 4item
  28. Voltage-gated Sodium (NaV) Channels 1 item
  29. Ribosomal s6 kinases (RSK) 1 item
  30. MET 5item
  31. Src 17item
  32. Trk Receptors 2item
  33. STAT 2item
  34. EGFR 18item
  35. ROCK 7item
  36. BTK 1 item
  37. PAK 3item
  38. FAK 4item
  39. BMP and Other Activin Receptors 2item
  40. JAK 15item
  41. Syk 5item
  42. DNA-PK 5item
  43. AMPK 2item
  44. PDHK 1 item
  45. Cytochrome P450 (CYP450) 1 item
  46. ErbB 4item
  47. S6 kinases 1 item
  48. Adenosine Kinases 2item
  49. ERK 4item
  50. Kinases 1 item
  51. c-MET 5item
  52. PKC 12item
  53. Ubiquitin-specific proteases 1 item
  54. Ca2 /calmodulin-dependent protein kinases (CaMKs) 6item
  55. Lyn 2item
  56. HER2 2item
  57. Pyk2 3item
  58. LRRK2 5item
  59. Insulin and Insulin-like Receptors 3item
  60. ALK 6item
  61. ROS1 1 item
  62. Sphingosine kinases (SphKs) 2item
  63. PKG 2item
  64. PKA 5item
  65. Myosin light chain kinases (MLCKs) 2item
  66. CaM-KK 1 item
  67. MELK 1 item
  68. Insulin-like growth factors (IGFs) 1 item
  69. Clk 1 item
  70. NUAK1 1 item
  71. NUAK2 1 item
  72. MK2 2item
  73. Angiotensin-Converting Enzymes (ACEs) 1 item
  74. Tie-2 2item
  75. RSK 2item
  76. phosphatases 1 item
  77. ATM/ATR 4item
  78. CK1 1 item
  79. Farnesyl Diphosphate Synthases 1 item
  80. CK2 3item
  81. HIPK2 1 item
  82. HIPK3 1 item
  83. P2X Receptors 1 item
  84. c-Fyn 1 item
  85. TAK1 1 item
  86. P110 1 item
  87. Hck 2item
  88. MNK 1 item
  89. 5-Lipoxygenases 1 item
  90. Insulin Receptors 1 item
  91. IRG-1R 1 item
  92. Cdc2-like kinase (Clk) 1 item
  93. eEF-2 1 item
  94. Cdc7 1 item
  95. ZAP-70 1 item
  96. c-RET 3item
  97. p70 rsk 2item
  98. VEGFR3/FLT4 1 item
  99. NTRK1/TRKA 1 item
  100. CSF-1R/c-Fms 1 item
  101. TAM kinase 1 item
  102. KDR 1 item
  103. Fyn kinase 1 item
  104. Abl kinases 1 item
  105. AXL 1 item
  106. c-Fms tyrosine kinase 1 item
  107. insulin 1 item
  108. haspin kinase 1 item
  109. STK 1 item
  110. MSK 1 item
  111. Lyn kinase 1 item
  112. Mer tyrosine kinase 1 item
  113. ErbB-2 1 item
  114. PDK-1 1 item
  115. Histone Acetyltransferases (HATs) 1 item
  116. Prk 1 item
  117. ITK 1 item
  118. NUAK 1 item
  119. DCLK2 1 item
  120. PTK 1 item
  121. phosphatidylinositol kinase 1 item
  122. Lck 1 item
  123. Flk1 2item
  124. glutamate release 1 item
  125. FGR 1 item
  126. YES 2item
  127. Fyn 2item
  128. ARG 1 item
  129. PKD 1 item
  130. Pyruvate kinases 1 item
  131. enoyl-acyl-carrier protein reductase 1 item
  132. Rho-kinase 1 item
  133. tropomyosin receptor kinase 1 item
  134. SK 1 item
  135. PPK 1 item
  136. c-Syk 1 item
  137. CDK1/CyclinB 1 item
  138. PIM1 kinase 1 item
  139. phospholipase A2 1 item
  140. ATM 1 item
  141. PIKfyve 1 item
  142. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 277item
  2. Cell Experiments 203item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 16item
  3. Adrenocortical Carcinoma 2item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 4item
  6. Bladder Carcinoma 1 item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 43item
  9. Cancer 195item
  10. Cervical Cancer 4item
  11. Cholangiocarcinoma 2item
  12. Chronic Lymphocytic Leukemia 2item
  13. Clear Cell Renal Cell Carcinoma 1 item
  14. Colon Cancer 19item
  15. Colon Carcinoma 2item
  16. Colorectal Cancer 19item
  17. Glioblastoma 16item
  18. Glioma 6item
  19. Hepatocellular Carcinoma 4item
  20. HIV Infections 1 item
  21. Immunological Diseases 1 item
  22. Inflammatory Bowel Disease 1 item
  23. Inflammatory Diseases 4item
  24. Leukemia 8item
  25. Liver Cancer 3item
  26. Lung Cancer 15item
  27. Lung Carcinoma 3item
  28. Lymphoma 9item
  29. Mantle Cell Lymphoma 1 item
  30. Melanoma 12item
  31. Multiple Myeloma 6item
  32. Myelofibrosis 1 item
  33. Myeloma 1 item
  34. Neuroblastoma 2item
  35. Non-small Cell Lung Cancer 5item
  36. Non-small Cell Lung Carcinoma 1 item
  37. Ovarian Cancer 14item
  38. Pancreatic Cancer 22item
  39. Prostate Cancer 17item
  40. Psoriasis 1 item
  41. Pulmonary Arterial Hypertension 1 item
  42. Renal Cancer 3item
  43. Renal Cell Carcinoma 5item
  44. Rheumatoid Arthritis 5item
  45. Thyroid Cancer 5item
  46. Type 2 Diabetes 2item